bile648
发表于 2025-3-23 10:27:30
Ethics of Placebo-Controlled Trials: Historical Analysis Including Experiences During the COVID-19 Pn bioethics. Since the onset of the HIV/AIDS pandemic in the 1980s, the issue of placebo-controlled trials after the discovery of efficacious drugs for HIV in the mid-1990s has sparked international controversy. This topic needs to be revisited with the experiences accumulated during the COVID-19 pa
cauda-equina
发表于 2025-3-23 14:33:57
Post-Trial Access: Historical Analysis Considering the Experience of COVID-19 Pandemictroversy at the end of the 1990s on clinical trials to overcome the HIV/AIDS pandemic. This ethical principle was drawn upon out of concern that sponsor companies would conduct placebo-controlled trials in resource poor countries that could not be conducted in wealthier parts of the world, and that
鬼魂
发表于 2025-3-23 22:00:09
Our “WMA Declaration of Helsinki”: Opinions and Proposals from Patient and Public for Research Ethic with the latest version being adopted in 2013. While it has been incorporated into research regulations in many countries and is well known to most researchers, most patients and the public see its title for the first time when they are requested to participate in medical research. We therefore for
倔强一点
发表于 2025-3-24 01:29:39
http://reply.papertrans.cn/32/3159/315889/315889_14.png
amnesia
发表于 2025-3-24 04:22:00
Development of Portfolios and Pipelines of Drugs for the Treatment, Prevention and Control of Neglech treatment and control measures have been developed. Product development partnerships (PDPs) have been established to bring forward new tools for these efforts. A huge movement, including international organizations, academia, pharmaceutical and biotech sectors, committed to advancing the treatment
冬眠
发表于 2025-3-24 07:22:32
Patient and Public Involvement (PPI) and Pharmaceutical Development Through Open Innovation Processevolvement activity started in the AIDS drug development programs. Reflecting the accumulated efforts of internationally active NPOs and other organizations, patient voices are now expanded in the drug development process. During the COVID-19 pandemic, new approaches, such as decentralized clinical t
Kaleidoscope
发表于 2025-3-24 13:59:30
http://reply.papertrans.cn/32/3159/315889/315889_17.png
archetype
发表于 2025-3-24 14:55:21
http://reply.papertrans.cn/32/3159/315889/315889_18.png
Cervical-Spine
发表于 2025-3-24 21:14:49
https://doi.org/10.1007/978-1-4684-5278-5al access and the use of placebos—are arguably more relevant than ever in light of the COVID-19 pandemic and the clinical trials for vaccines that were performed in an expedited manner. These and other issues must be examined regularly to ensure the continued applicability of this core WMA document.
栖息地
发表于 2025-3-24 23:17:34
http://reply.papertrans.cn/32/3159/315889/315889_20.png